BMS-002
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
lysophosphatidic acid (LPA) receptor-1
Description:
BMS-002 is a selective antogonist of lysophosphatidic acid (LPA) receptor-1 developed to treat diabetic nephropathy. In eNOS-/- db/db mouse model, BMS-002 significantly decreased the level of proteinuria.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
antogonist of LPA receptor-1, diabetic nephropathy
MSDS:
Inquire
Application:
the potential treatment of diabetic nephropathy
Current Developer:
Bristol-Myers Squibb
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items